ישראל - עברית - Ministry of Health

raz pharmaceutics ltd, israel - treosulfan - אבקה להכנת תמיסה לאינפוזיה - treosulfan 5 g/vial - treosulfan

ישראל - עברית - Ministry of Health

tradis gat ltd - citric acid anhydrous; light magnesium oxide; sodium picosulfate - אבקה להכנת תמיסה - citric acid anhydrous 10.97 g; light magnesium oxide 3.5 g; sodium picosulfate 10 mg - sodium picosulfate, combinations

ישראל - עברית - Ministry of Health

hope pharmaceuticals ltd, israel - sodium nitrite; sodium thiosulfate - תמיסה להזרקה - sodium thiosulfate 250 mg / 1 ml; sodium nitrite 30 mg / 1 ml - thiosulfate

ישראל - עברית - Ministry of Health

hope pharmaceuticals ltd, israel - sodium thiosulfate - תמיסה להזרקה - sodium thiosulfate 250 mg / 1 ml - thiosulfate

ישראל - עברית - Ministry of Health

teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - citric acid anhydrous; magnesium oxide; sodium picosulfate - אבקה להכנת תמיסה - citric acid anhydrous 12 g; magnesium oxide 3.5 g; sodium picosulfate 10 mg - sodium picosulfate, combinations

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - citric acid anhydrous; magnesium oxide; sodium picosulfate - אבקה להכנת תמיסה - sodium picosulfate 10 mg; citric acid anhydrous 12 g; magnesium oxide 3.5 g - citric acid - citric acid - to clean the bowel prior to x-ray examination, endoscopy or surgery.

ישראל - עברית - Ministry of Health

euromar ltd - avilamycin - פרמיקס - avilamycin 100 g/kg